ODDB.org: Open Drug Database

Swissmedic Registration	67862	Date of registration	08.02.2021
Company name	Eli Lilly (Suisse) SA	Revision date
		Valid until	19.12.2029
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Retsevmo 40 mg	gélules	Capsules (Selpercatinibum 40 mg)	L01EX22	CI
02	Retsevmo 80 mg	gélules	Capsules (Selpercatinibum 80 mg)	L01EX22

2025	©ywesee GmbH